Community Care Team Workshops: New Frontline Strategies Challenge Longtime Standards in DLBCL

Download All
In this comprehensive program for oncology professionals, learn how the hematology/oncology experts are incorporating novel treatments for newly diagnosed diffuse large B-cell lymphoma, during a live interdisciplinary team workshop series, 3-live simulcasts, an on-demand webcast capturing a live CCO community workshop, an expert commentary, and a downloadable slideset to help facilitate shared decision-making with your patients.
Brad S. Kahl, MD

ClinicalThought

In this commentary, I will address how diffuse large B cell lymphoma looks at presentation, discuss how current frontline treatment varies among patient subgroups, and review recent data supporting polatuzumab vedotin plus R-CHP as an improvement vs R-CHOP.

Brad S. Kahl, MD Released: March 3, 2022
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings